Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS Pharmaceutical's Accounts Payable for the quarter that ended in Feb. 2026 was 円177,933 Mil.
COSMOS Pharmaceutical's quarterly Accounts Payable
increased
from Aug. 2025 (円178,973 Mil) to Nov. 2025 (円186,357 Mil) but then
declined
from Nov. 2025 (円186,357 Mil) to Feb. 2026 (円177,933 Mil).
COSMOS Pharmaceutical's annual Accounts Payable
declined
from May. 2024 (円179,549 Mil) to May. 2025 (円177,125 Mil) but then
increased
from May. 2025 (円177,125 Mil) to May. 2026 (円195,796 Mil).
COSMOS Pharmaceutical Accounts Payable Related Terms
COSMOS Pharmaceutical Accounts Payable Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Accounts Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
What does a Accounts Payable of 円177,933 Mil mean?
COSMOS Pharmaceutical (TSE:3349) has a Accounts Payable of 円177,933 Mil as of Feb. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on COSMOS Pharmaceutical and its competitors.
Is COSMOS Pharmaceutical's Accounts Payable too high?
COSMOS Pharmaceutical's current Accounts Payable is 円177,933 Mil. Overall, COSMOS Pharmaceutical has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Accounts Payable compare to competitors?
COSMOS Pharmaceutical's Accounts Payable of 円177,933 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Healthcare Providers & Services company?
A good Accounts Payable depends on the Healthcare Providers & Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on COSMOS Pharmaceutical and its competitors. COSMOS Pharmaceutical's current Accounts Payable is 円177,933 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (TSE:3349) is currently considered Modestly Undervalued. The stock's GF Value™ is 円8,450.64, compared to a current price of 円6,612.00 — trading 21.8% below its estimated fair value. The current Accounts Payable is 円177,933 Mil. COSMOS Pharmaceutical's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For COSMOS Pharmaceutical (TSE:3349), the current Accounts Payable is 円177,933 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (TSE:3349) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of 円6,612.00 is trading 21.8% below its estimated GF Value™ of 円8,450.64.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for TSE:3349:
Accounts Payable: 円177,933 Mil
GF Value™: 円8,450.64 vs. price of 円6,612.00 (21.8% below fair value)
No single metric tells the full story. See the TSE:3349 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
89GF Score
Get the complete analysis for TSE:3349
Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3349 has been successfully added to your 
